Births following fertility treatment in the GUI infant cohort. Aisling Murray Growing Up in Ireland, ESRI

Similar documents
International Federation of Fertility Societies. Global Standards of Infertility Care

Dr Manuela Toledo - Procedures in ART -

Assisted reproductive technology and intrauterine inseminations in Europe, 2005: results generated from European registers by ESHRE

Artigo original/original Article

Infertility F REQUENTLY A SKED Q UESTIONS. Q: Is infertility a common problem?

GENA2. Source Booklet. General Studies (Specification A) General Certificate of Education Advanced Subsidiary Examination June 2011

European IVF Monitoring (EIM) Year: 2013

Men s consent to the use and storage of sperm or embryos for surrogacy

Embryo Selection after IVF

DRAFT Policy for the Provision of NHS funded Gamete Retrieval and Cryopreservation for the Preservation of Fertility

NICE fertility guidelines. Hemlata Thackare MPhil MSc MRCOG Deputy Medical Director London Women s Clinic

Infertility. Thomas Lloyd and Samera Dean

European IVF Monitoring (EIM) Year: 2012

Your consent to the use of your sperm in artificial insemination

Understanding IVF Processes in Surrogacy

WHAT IS A PATIENT CARE ADVOCATE?

INTRACYTOPLASMIC SPERM INJECTION

Brighton & Hove CCG PLS CONFERENCE Dr Carole Gilling-Smith Medical Director

Intrauterine (IUI) and Donor Insemination (DI) Policy (excluding In vitro fertilisation (IVF) & Intracytoplasmic sperm injection (ICSI) treatment)

WHO ARE THE DONORS? - An HFEA Analysis of donor registrations and use of donor gametes over the last 10 years

Adoption and Foster Care

Society for Assisted Reproductive Technology and American Society for Reproductive Medicine

Supplemental figure 1. Adjusted odds ratios for gestational diabetes, pre-eclampsia, premature birth and miscarriage for women with and without PCOS.

NHS FUNDED TREATMENT FOR SUBFERTILITY. ELIGIBILITY CRITERIA POLICY GUIDANCE/OPTIONS FOR CCGs

Fertility Policy. December Introduction

COMMISSIONING POLICY. Tertiary treatment for assisted conception services

Infertility treatment

Fertility 101. About SCRC. A Primary Care Approach to Diagnosing and Treating Infertility. Definition of Infertility. Dr.

Recommended Interim Policy Statement 150: Assisted Conception Services

St Helens CCG NHS Funded Treatment for Subfertility Policy 2015/16

HALTON CLINICAL COMMISSIONING GROUP NHS FUNDED TREATMENT FOR SUBFERTILITY. CONTENTS Page

Fertility assessment and assisted conception

Fertility Services Commissioning Policy

Assisted Reproductive Technologies

Supplementary Online Content

Treating Infertility

Couples Information Leaflet

Biology of fertility control. Higher Human Biology

ASSISTED CONCEPTION NHS FUNDED TREATMENT FOR SUBFERTILITY ELIGIBILITY CRITERIA & POLICY GUIDANCE

Sperm Donation - Information for Donors

Clomid and twin pregnancy rates

Fertility treatment and referral criteria for tertiary level assisted conception

Blackpool CCG. Policies for the Commissioning of Healthcare. Assisted Conception

Intrauterine Insemination - FAQs Q. How Does Pregnancy Occur?

Infertility. F r e q u e n t l y A s k e d Q u e s t i o n s. Q: What causes infertility in men? A: Infertility in men is most often caused by:

Female Reproductive Physiology. Dr Raelia Lew CREI, FRANZCOG, PhD, MMed, MBBS Fertility Specialist, Melbourne IVF

Report to the Director-General of Health on the Risks and Benefits Associated with Assisted Reproductive Technologies

East and North Hertfordshire CCG. Fertility treatment and referral criteria for tertiary level assisted conception

Fertility treatment and referral criteria for tertiary level assisted conception

Assisted Conception Policy

Fertility treatment in trends and figures

WOMEN & INFANTS HOSPITAL Providence, RI CONSENT FOR IN VITRO FERTILIZATION USING A GESTATIONAL CARRIER (PATIENT/INTENDED PARENTS) 1.

Policy updated: November 2018 (approved by Haringey and Islington s Executive Management Team on 5 December 2018)

Welcome. Fertility treatment can be complicated. What s included. Your fertility treatment journey begins here. Fertility treatment basics 2

In Vitro Fertilization What to expect

In Vitro Fertilization

Dr Guy Gudex. Director Repromed. 17:00-17:30 Recent Advances in Fertility Management

Clinical Policy Committee

DRAFT Policy for Assisted Conception

Fertility Services Commissioning Policy

Articles Follow-up of children born after assisted reproductive technologies

CHAPTER 4 REPRODUCTIVE HEALTH POINTS TO REMEMBER

MONITORING ASSISTED REPRODUCTIVE TECHNOLOGIES ROMANIAN EXPERIENCE

Policy statement. Commissioning of Fertility treatments

COMMISSIONING POLICY SPECIALISED FERTILITY SERVICES

FACT SHEET. Failure of Ovulation Blocked or Damaged Fallopian TubesHostile Cervical Mucus Endometriosis Fibroids

MST and PNT allow eggs or embryos to be created for you containing your and your partner s nuclear genetic material D D M M Y Y D D M M Y Y

SHIP8 Clinical Commissioning Groups Priorities Committee (Southampton, Hampshire, Isle of Wight and Portsmouth CCGs)

Approved January Waltham Forest CCG Fertility policy

COMMISSIONING POLICY FOR IN VITRO FERTILISATION (IVF)/ INTRACYTOPLASMIC SPERM INJECTION (ICSI) WITHIN TERTIARY INFERTILITY SERVICES V2.

Fertility Preservation By Dr Mary Birdsall Chair, Fertility Associates

Reproductive Technology and Its Impact on Child Psychosocial and Emotional Development

Haringey CCG Fertility Policy April 2014

WOMEN & INFANTS HOSPITAL Providence, RI CONSENT FOR IVF WITH EMBRYO TRANSFER

North Staffordshire Clinical Commissioning Group. Infertility and Assisted Reproduction Commissioning Policy and Eligibility Criteria

reproductive M E D I C I N E

Your consent to your sperm and embryos being used in treatment and/or stored (IVF and ICSI)

CEL 09 (2013) 15 May Dear Colleague

Commissioning Policy For In Vitro Fertilisation (IVF) / Intracytoplasmic Sperm Injection (ICSI) within Tertiary Infertility Services

Bumiputera Sarawak Bumiputera Sabah. Others Foreigner. Had previous natural pregnancy Previous IVF pregnancies. IVF live births.

Fertility in the 21 st Century Dr Leigh Searle

Reproductive Technology, Genetic Testing, and Gene Therapy

Clinical Policy Committee

FEMALE MEDICAL & REPRODUCTIVE HISTORY (There are 5 pages - please ensure you answer all questions)

Fertility Services Commissioning Policy

Wiltshire CCG Fertility Policy

WOLFSON FERTILITY CENTRE. Wolfson Fertility Centre

JAWDA Quarterly & Yearly Guidelines for Assisted Reproductive Technology Treatment (ART) Providers January 2019

Assisted Reproductive Technologies

COMMISSIONING POLICY FOR IN VITRO FERTILISATION (IVF)/ INTRACYTOPLASMIC SPERM INJECTION (ICSI) WITHIN TERTIARY INFERTILITY SERVICES

Your consent to donating your eggs

UW MEDICINE PATIENT EDUCATION. In Vitro Fertilization How to prepare and what to expect DRAFT

Patient Price List. t: e: w:

IVF Health Risk 503,000 Hit in Google in 0.2 seconds

IN VITRO FERTILISATION (IVF)

Health Service System City & County of San Francisco

PhD THESIS SARA SOFIA MALCHAU LAUESGAARD ACADEMIC SUPERVISORS

Bromley CCG Assisted Conception Funding Form Checklist for Eligibility Criteria for NHS funding of Assisted Conception

10/16/2014. Adolescents (ages 10 19) and young adults (ages 20 24) together compose about 21% of the population of the United States.

Transcription:

Births following fertility treatment in the GUI infant cohort www.growingup.ie Aisling Murray Growing Up in Ireland, ESRI

About GUI Two cohorts: birth (9 months) and middle childhood (9 years) Current paper using the birth cohort when parents were interviewed just after the study child turned 9- months-old 11,134 children selected from Child Benefit Register Questions about fertility treatments were asked of biological mothers during the self-complete section

Fertility Treatments in Ireland In Ireland, procedures such as IVF are carried out mostly in private clinics Drug treatments may be available through a GP Difficult to be certain how many Irish births are as a result of fertility treatments Reports from European Society of Human Reproduction and Embryology Six (out of 7) clinics reported 465 deliveries between them in 2004 using technologies such as IVF, ICSI and Frozen Embryo Replacement (2008 report) 787 deliveries between six (out of 7) clinics in 2006 (2010 report)

Types of Fertility Treatment Clomiphene citrate Drug which boosts egg production In Vitro Fertilisation (IVF) Egg and sperm are fused in a laboratory and then the fertilised egg is placed in the uterus Intra-Cyclic Sperm Injection (ICSI) Similar to IVF except a single sperm is injected into the egg Frozen Embryo Transfer Similar to IVF but using an embryo that has been preserved from an earlier cycle Intra-Uterine Insemination Selected sperm are placed in the womb close to the time of ovulation Donor sperm/eggs Sperm, egg or both utilised instead of prospective parent s (parents ) own genetic material Typically used in conjunction with the other treatment types Gamete Intra-Fallopian Transfer Egg and sperm placed in the fallopian tube so that fertilisation takes place internally Other options Surgery, hormone treatment

Use of fertility treatments 4.2% of all children in the sample were born following some form of fertility treatment Circa 3,000 children in a year s cohort No significant gender difference 52.5% boys and 47.5% girls Most common techniques (within fertility treatments) were clomiphene citrate alone (30.9%) and IVF (28.4%) Respondents chose one treatment from a pre-defined list

Types of Fertility Treatment 12.9 Clomiphene citrate alone 6.6 30.9 In Vitro Fertilisation (IVF) 7.6 13.3 28.4 Intra Cytoplasmic Sperm Injection (ICSI) Other transfers and donor sperm/eggs Surgery/hormone treatment Other incl Intrauterine Insemination (IUI)

Socio-Demographic Characteristics 62.9% were born in to the top-two income quintiles 95% into two-parent families (at 9-months) 58.9% of all fertility treatment births were to mothers aged 35 years or older 29.9% born to mothers aged 30-34 years 11.3% of all mothers over 40 who gave birth had some sort of fertility treatment

Common Risk Factors Births following fertility treatment have been associated with a greater risk of multiple birth Particularly drug treatments and IVF (e.g. Basit et al, 2010; Allen et al, 2008) Multiple births associated with increased risk for pre-eclampsia, diabetes in pregnancy, cerebral palsy, low birth-weight and premature birth (Human Fertility & Embryology Authority, 2006) Low birth-weight/prematurity associated with a higher risk of various health, cognitive and behavioural problems (e.g. Ashdown-Lambert, 2005; Aylward, 2005) Low birth-weight was associated with lower scores on three out of five developmental indices for GUI infants (Williams et al, 2010) Some negative outcomes not detected until the child is older

Multiple Births 17% of all fertility-treatment pregnancies in GUI resulted in a multiple birth (unadjusted odds ratio of 8.82) 2.3% for all other pregnancies Higher incidence of multiple births may explain higher rates of low birth-weight and prematurity Some studies show increased risk post fertility-treatment for singleton births also (Allen et al, 2008)

Low Birth-Weight 14.4% of infants born using fertility treatment were low birth-weight ( < 2500g) 5.2% non-fertility births Looking at singleton births only, reduces this comparison to 7.1% (fertility) and 4.0% (non-fertility)

Odds Ratio for Low Birthweight Low Birth-Weight Model including twins 10 9 8 7 6 5 4 3 3.03 3.03 3.13 3.40 Adjusting for a multiple- birth reduces risk of being low birthweight for infants born following fertility treatment 2 1.53 1 0 Fertility treatment only*** Add gender *** Add maternal age*** Add income*** Add nonsingleton* *** p <.001, **p<.01, *p<.05

Odds Ratio for Low Birthweight Low Birth-Weight Model excluding twins 10 9 8 7 6 5 4 Effect of fertility treatment also significant for singletons 3 2 1.86 1.86 1.98 2.10 1 0 Fertility treatment only** Add gender ** Add maternal age** Add income** *** p <.001, **p<.01, *p<.05

Premature Births 13.8% of all fertility-treatment infants were born at 36 weeks or earlier Compared to 6.1% of non-fertility infants Rates are 7.4% and 5.2% respectively when looking just at singletons

Odds Ratio for Premature Birth Premature Births Model including twins 10 9 8 7 6 5 4 3 2 2.62 2.61 2.62 2.88 1.43 Adjusting for multiple-births reduces risk of premature birth to marginal significance (p =.05) 1 0 Fertility treatment only*** Add gender *** Add maternal age*** Add income*** Add nonsingleton* *** p <.001, **p<.01, *p<.05

Odds Ratio for Premature Birth Premature Births Model excluding twins 10 9 8 7 6 5 4 3 Analysis on singleton births only, shows similar marginal effect of fertility treatment 2 1.55 1.55 1.61 1.73 1 0 Fertility treatment only* Add gender * Add maternal age* Add income* *** p <.001, **p<.01, *p<.05

Health Status at Birth Infants born using fertility treatments were less likely to have been described as very healthy, no problems at birth 72.8% (fertility) compared to 80.6% (non-fertility) Difference reduced to 77.1% v 81.2% when looking only at singleton births

Odds Ratio for No Health Problems at Birth Very Healthy at Birth including twins 1 0.9 0.8 0.7 0.6 0.5 0.4 0.3 0.62 0.62 0.62 0.62 0.76 The negative effect of fertility treatment on health at birth is reduced post adjustment for multiple births 0.2 0.1 0 Fertility treatment only*** Add gender *** Add maternal age*** Add income*** Add nonsingleton* *** p <.001, **p<.01, *p<.05

Odds Ratio for No Health Problems at Birth Very Healthy at Birth excluding twins 1 0.9 0.8 0.7 0.6 0.5 0.4 0.3 0.2 0.1 0 0.77 0.77 0.77 0.78 Fertility treatment only - p=.051 Add gender - p=.051 Add maternal age - p=0.50 Add income - p =.060 For singletons, the negative effect of fertility treatment is marginally significant *** p <.001, **p<.01, *p<.05

Health at 9-Months Infants born following fertility treatment were just as likely to be rated as very healthy, no problems by the age of 9 months 85.8% (fertility) to 82.9% (non-fertility)

Odds Ratio for No Health Problems at 9 Months Health at 9 Months 5 4.5 4 3.5 3 2.5 2 1.5 1 0.5 0 1.23 1.24 1.18 1.18 1.17 Fertility treatment only Add gender Add maternal age Add income Add nonsingleton No effect of fertility treatment on ratings of very healthy, no problems by 9-monthsold

Maternal Attachment Some research (e.g. Golombok et al, 1996) suggests mothers who have used fertility treatment feel more positively towards their infants Maternal attachment measured at 9 months in GUI using Condon & Corkindale quality of attachment subscale All mothers completed likert-type scales during main interview E.g. I feel <child> is very much my own baby No difference between mothers on basis of fertility treatment (mean =42.4) compared to other mothers (mean=42.6) Very high levels of attachment reported across the sample

Relationship to Spouse/Partner Mothers and fathers were asked if the birth of the study child had made them closer to their partner, less close or made no difference Mothers, and fathers, of infants born using fertility treatments were more likely to report that the birth brought them closer together More marked for mothers than fathers

% of Parents Relationship to Spouse/Partner 100 100 90 80 81.9 74.5 90 80 82.9 78.5 70 70 60 50 60 50 40 30 20 13.6 20.4 40 30 20 17.7 13.4 Fertility Treatment Others 10 4.5 5.1 10 3.7 3.8 0 Brought closer together No difference Less close than before Mothers 0 Brought closer together No difference Less close than before Fathers

Summary - Infants Infants born following fertility treatments are: Much higher risk of being part of a multiple birth Greater risk of low birth-weight and premature births Largely accounted for by greater risk of multiple birth Less likely to be in excellent health at birth, but no difference by the time he/she is 9-months-old

Summary - Mothers Mothers of infants born following fertility treatments are more likely to: Be in higher income groups Be over 30 years Live with a spouse/partner Report that the birth of the child had brought she and her partner closer together, but do not differ in terms of their attachment to the infant

Limitations Infants were selected at age nine-months Excludes fertility-treatment pregnancies that resulted in miscarriages, still births or early neonatal deaths Even with a large sample, small cell sizes are reached quickly when dividing into subgroups Need to disentangle apparent effects of a fertility treatment from the biological reason that such a treatment was required Don t know if parents who used fertility treatments would be more or less likely to participate in a study of this kind GUI somewhat higher than overall UK rate (2006) for assisted technologies

Advantages of GUI data Children were selected randomly from the population Comparison to children not resulting from fertility treatments Possibility of matching on other shared characteristics Data collected within a year of the child s birth Wide range of other data collected Health of children and parents, pregnancy complications, development, socio-demographic characteristics Data will be longitudinal Fieldwork on age 3 visit completed this year

Possibilities for Future Study Comparison on developmental indicators Is higher risk of low birth-weight/prematurity balanced by greater likelihood of other socio-economic advantages? Cross-sectional and longitudinal possibilities Relative risk for pregnancy, birth or health complications Possibly by type of treatment Dependent on sufficient cell size Family dynamics as the child gets older

References Allen, C., Bowdin, S., Harrison, R.F. et al. (2008). Pregnancy and perinatal outcomes after assisted reproduction: A comparative study. Irish Journal of Medicine Sciences, 177, 233-241. Aylward, G.P. (2005). Neurodevelopmental outcomes of infants born prematurely. Developmental and Behavioral Pediatrics, 26, 6, 427 440. Ashdown-Lambert, J.R. (2005). A review of low birth weight: predictors, precursors and morbidity outcomes. The Journal of the Royal Society for the Promotion of Health, 125, 2, 76-83. Basit, I., Johnson, S., Mocanu, E., Geary, M., Wingfield, D. & Daly, S. (2010). Mode of conception of triplets and high order multiple pregnancy in Dublin a 10-year review [Poster presentation at the 14 th British Maternal and Fetal Medicine Society Annual Conference]. Archives of Disease in Childhood Fetal and Neonatal Edition, 95, Supplement 1. de Mouzon, J., Goossens, V., Bhattacharya, S. et al. (2010). Assisted reproductive technology in Europe, 2006: Results generated from European Registers by ESHRE. Human Reproduction, 25, 8, 1851-1862. Golombok, S., Brewaeys, A., Cook, R., Giavazzi, M. T., Guerra, D., Mantovani, A., van Hall, E., Crosignani, P.G. & Dexeus, S. (1996) The European Study of Assisted Reproduction Families. Human Reproduction, 11, No 10, 2324-2331. Human Fertility & Embryology Association. (2006). Multiple Pregnancies and Births: Considering the Risks [factsheet]. Available from http://www.hfea.gov.uk/cps/rde/xbcr/sid-3f57d79b- CC25CD59/hfea/multiple_births_final_Nov06.pdf. Nyboe Andersen, A., Goossens, V. Ferraretti, A.P. et al. (2008). Assisted reproductive technology in Europe, 2004: Results generated from European Registers by ESHRE. Human Reproduction, 23, 4, 756-771. Williams, J., Greene, S., McNally, S., Murray, A. & Quail, A. (2010). Growing Up in Ireland: The Infants and Their Families. Dublin: Stationery Office.